肌萎缩侧索硬化诊断指数:迈向ALS的个性化诊断
这项前瞻性多中心研究纳入407例疑似ALS患者,随机分为训练集(75%)和测试集(25%),开发并验证了新型ALS诊断指数(ALSDI)。ALSDI在训练集和测试集中均能可靠区分ALS与模拟疾病,且对Awaji阴性及下运动神经元为主表型患者同样有效。
要点
- ALSDI≥4在训练集敏感性81.6%、特异性89.6%、准确率83.5%。
- ALSDI≥4在测试集敏感性83.3%、特异性84%、准确率83.5%。
- ALSDI对Awaji阴性及下运动神经元为主表型患者仍有诊断价值。
核心结论
- ALSDI可在疾病早期可靠区分ALS与模拟疾病。
研究设计与样本
- 前瞻性多中心研究,纳入407例疑似ALS患者,随机分为训练集(75%)和测试集(25%),以Awaji标准为参考标准。
主要发现
- 训练集AUC 0.92(95%CI 0.89-0.95),ALSDI≥4敏感性81.6%、特异性89.6%、准确率83.5%。
- 测试集AUC 0.90(95%CI 0.84-0.97),ALSDI≥4敏感性83.3%、特异性84%、准确率83.5%。
- 在Awaji阴性及下运动神经元为主表型患者中诊断效用得到确认。
关键数值与推荐
- ALSDI≥4为诊断阈值,训练集敏感性81.6%、特异性89.6%、准确率83.5%。
- 测试集ALSDI≥4敏感性83.3%、特异性84%、准确率83.5%。
临床怎么用
- 对于疑似ALS患者,可采用ALSDI≥4辅助早期区分ALS与模拟疾病。
- 对Awaji阴性或下运动神经元为主表型患者,ALSDI仍可提供诊断参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the study was to assess the utility of a novel amyotrophic lateral sclerosis (ALS) diagnostic index (ALSDI). METHODS: A prospective multicenter study was undertaken on patients presenting with suspected ALS. The reference standard (Awaji criteria) was applied to all patients at recruitment. Patients were randomly assigned to a training (75%) and a test (25%) cohort. The ALSDI was developed in the training cohort and its diagnostic utility was subsequently assessed in the test cohort. RESULTS: A total of 407 patients were recruited, with 305 patients subsequently diagnosed with ALS and 102 with a non-ALS mimicking disorder. The ALSDI reliably differentiated ALS from neuromuscular disorders in the training cohort (area under the curve 0.92, 95% confidence interval 0.89-0.95), with ALSDI ≥4 exhibiting 81.6% sensitivity, 89.6% specificity, and 83.5% diagnostic accuracy. The ALSDI diagnostic utility was confirmed in the test cohort (area under the curve 0.90, 95% confidence interval 0.84-0.97), with ALSDI ≥4 exhibiting 83.3% sensitivity, 84% specificity, and 83.5% diagnostic accuracy. In addition, the diagnostic utility of the ALSDI was confirmed in patients who were Awaji negative at recruitment and in those exhibiting a predominantly lower motor neuron phenotype. CONCLUSION: The ALSDI reliably differentiates ALS from mimicking disorders at an early stage in the disease process. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for patients with suspected ALS, the ALSDI distinguished ALS from neuromuscular mimicking disorders.
引用
- Geevasinga N, Howells J, Menon P, et al. Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS. Neurology. 2019. PMID: 30709964. doi:10.1212/WNL.0000000000006876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。